| Date Filed | Type | Description |
| 06/16/2023 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 03/31/2023 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $1.55, valued at
$7.8k
|
|
| 06/24/2022 |
4
| Jones Elaine V (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $4.77, valued at
$68k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Jones Elaine V (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,000 options to buy
@ $9.86, valued at
$187.3k
|
|
| 06/28/2021 |
4
| Jones Elaine V (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $8.21, valued at
$117k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2020 |
4
| Jones Elaine V (Director) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 12,500 options to buy
@ $6.66, valued at
$83.3k
|
|
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Jones Elaine V (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $24.13, valued at
$343.9k
|
|
| 09/13/2019 |
4
| Jones Elaine V (Director) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 15,942 options to buy
@ $10.2, valued at
$162.6k
|
|
| 09/13/2019 |
3
| Jones Elaine V (Director) has filed a Form 3 on Gritstone Oncology, Inc. |
| 06/21/2019 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 14,000 options to buy
@ $11.31, valued at
$158.3k
|
|
| 06/17/2019 |
4
| Jones Elaine V (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 22,000 options to buy
@ $15.57, valued at
$342.5k
|
|
| 05/08/2019 |
3
| Jones Elaine V (Director) has filed a Form 3 on NextCure, Inc. |
| 05/02/2019 |
4
| Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 28,000 options to buy
@ $9.35, valued at
$261.8k
|
|
| 05/02/2019 |
3
| Jones Elaine V (Director) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 06/27/2017 |
3
| Jones Elaine V (Director) has filed a Form 3 on Mersana Therapeutics, Inc. |